|
|
|
| home > white papers > The Power of Execution in Clinical Research - Medpace |
|
|
 WHITE PAPERS |
|
Medpace
|
|
The Power of Execution in Clinical Research
|
|
Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Kuehne+Nagel and X’s Project Chorus partner to enhance global supply chain visibility and resilience
Schindellegi / CH, March 16, 2022 – Kuehne+Nagel and Chorus, a
moonshot project at X, Alphabet’s Moonshot Factory, partner to offer
select Kuehne+Nagel Road Logistics customers real-time solutions and
granular, prescriptive insights into the health and state of their
global supply chain and logistics operations.
More info >> |
|
 |
White Papers |
 |
|
The Promise and Challenge of Adaptive Design in Oncology Trials
Medpace
Clinical oncology trials are more complex and time consuming than those
in any other therapeutic area and failure rates are frustratingly high.
Given the urgent need for new oncologic therapies, sponsors are eager to
find more effective ways to conduct clinical research.
Incorporating adaptive design methodologies into clinical trials can
reduce costs and enhance efficiency while maintaining trial integrity.
They can also reduce the number of patients on placebo and
sub-therapeutic doses. In light of this promise, regulatory bodies have
created guidelines supportive of adaptive design.
More info >> |
|
|
|
